SciELO - Scientific Electronic Library Online

 
vol.22 issue8Outcome of patients with suspected pulmonary thromboembolism and low probability ventilation/perfusion lung scan who receive no long-term anticoagulationMeningoencephalitis by Listeria in the lupus disease author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Anales de Medicina Interna

Print version ISSN 0212-7199

Abstract

BLANCO BARRIOS, A.; ZANCADA DIAZ DE ENTRE-SOTOS, F.; GUTIERREZ VIVAS, A.  and  CALDERON MARINO, N.. Progressive multifocal leucoencephlopathy in AIDS patients: Hepatotoxicity of HAART in patients with hepatitis B or C. An. Med. Interna (Madrid) [online]. 2005, vol.22, n.8, pp.376-378. ISSN 0212-7199.

Progressive multifocal leukoencephalopathy (PML) develops in 1-8% of patients with AIDS, for which it is a disease-defining condition. PML presents mainly in severely immunocompromised male intravenous drug users, having viral loads greater than log5 RNA copies/mL and CD4 populations lower than 150 cells/mm3. Death of AIDS patients with PML occurred after only 4 to 6 months before the introduction of highly active antiretroviral therapies (HAART), the only ones that have shown to prolong survival. Viral hepatitis is not the only liver condition affecting patients with AIDS, opportunistic infections and neoplasms, such as lymphoma and Kaposi´s sarcoma, as well as biliary disease are also encountered but, fortunately, they are currently less frequent as a result of the new antiretroviral treatments. The risks of HAART hepatotoxicity in patients with hepatitis B or C have been studied by several groups.

Keywords : Progressive multifocal leucoencephalopathy; AIDS; Hepatotoxicity of HAART in patients with hepatitis B or C.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License